MX360453B - Cromatografia de membrana de intercambio ionico. - Google Patents

Cromatografia de membrana de intercambio ionico.

Info

Publication number
MX360453B
MX360453B MX2014007622A MX2014007622A MX360453B MX 360453 B MX360453 B MX 360453B MX 2014007622 A MX2014007622 A MX 2014007622A MX 2014007622 A MX2014007622 A MX 2014007622A MX 360453 B MX360453 B MX 360453B
Authority
MX
Mexico
Prior art keywords
polypeptide
membrane
ion exchange
effluent
interest
Prior art date
Application number
MX2014007622A
Other languages
English (en)
Other versions
MX2014007622A (es
Inventor
Joseph Bill Jerome
Michael Brown Arick
John Dowd Christopher
Ellen Thayer Brooke
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47430154&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX360453(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2014007622A publication Critical patent/MX2014007622A/es
Publication of MX360453B publication Critical patent/MX360453B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361Ion-exchange
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/165Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Abstract

La presente invención se refiere a métodos para mejorar la eficacia de las etapas de la cromatografía corriente abajo para la purificación de proteínas que comprende: (a) pasar una composición que comprende un polipéptido de interés y diversos contaminantes a través de una membrana de intercambio iónico, en donde el polipéptido y la membrana tienen carga opuesta, en condiciones operativas compuestas por un amortiguador que tiene un pH lo suficientemente diferente del pI del polipéptido como para mejorar la carga del polipéptido y una fuerza iónica baja eficaz para evitar el blindaje de las cargas por los iones del amortiguador, lo que provoca que la membrana se una al polipéptido y al menos a un contaminante, (b) sobrecargar la membrana de intercambio jónico de modo que al menos un contaminante permanezca unido a la membrana mientras el polipéptido de interés se encuentra principalmente en el efluente; (c) recolectar el efluente de la membrana de intercambio jónico que comprende el polipéptido de interés; (d) someter el efluente de la membrana que comprende el polipéptido de interés a una etapa de purificación de carga similar a la membrana anterior y (e) recuperar el polipéptido purificado del efluente de la etapa de purificación por cromatografía de intercambio iónico cargada.
MX2014007622A 2011-12-22 2012-12-18 Cromatografia de membrana de intercambio ionico. MX360453B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161579285P 2011-12-22 2011-12-22
PCT/US2012/070373 WO2013096322A1 (en) 2011-12-22 2012-12-18 Ion exchange membrane chromatography

Publications (2)

Publication Number Publication Date
MX2014007622A MX2014007622A (es) 2014-09-22
MX360453B true MX360453B (es) 2018-11-01

Family

ID=47430154

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014007622A MX360453B (es) 2011-12-22 2012-12-18 Cromatografia de membrana de intercambio ionico.
MX2018013356A MX2018013356A (es) 2011-12-22 2014-06-20 Cromatografia de membrana de intercambio ionico.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2018013356A MX2018013356A (es) 2011-12-22 2014-06-20 Cromatografia de membrana de intercambio ionico.

Country Status (22)

Country Link
US (3) US10364268B2 (es)
EP (2) EP3492486A1 (es)
JP (5) JP6605202B2 (es)
KR (3) KR20210025692A (es)
CN (2) CN104125963B (es)
AR (1) AR089362A1 (es)
AU (3) AU2012355356B2 (es)
BR (1) BR112014015101A8 (es)
CA (1) CA2859376C (es)
ES (1) ES2697676T3 (es)
HK (1) HK1203526A1 (es)
HR (1) HRP20181846T1 (es)
IL (2) IL267585B (es)
MX (2) MX360453B (es)
MY (1) MY172426A (es)
PL (1) PL2794635T3 (es)
RU (1) RU2648999C2 (es)
SG (1) SG11201403437TA (es)
SI (1) SI2794635T1 (es)
TR (1) TR201815709T4 (es)
WO (1) WO2013096322A1 (es)
ZA (2) ZA201404593B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6605202B2 (ja) * 2011-12-22 2019-11-13 ジェネンテック, インコーポレイテッド イオン交換膜クロマトグラフィー
CN110054661A (zh) 2013-12-12 2019-07-26 Emd密理博公司 使用含丙烯酰胺的过滤器分离蛋白
CA3233584A1 (en) 2013-12-27 2015-07-02 Chugai Seiyaku Kabushiki Kaisha Method for purifying antibody having low isoelectric point
CN104693303B (zh) * 2015-02-28 2018-03-13 苏州金盟生物技术有限公司 一种蛋白制品中的核酸去除方法
WO2017027861A1 (en) 2015-08-13 2017-02-16 Amgen Inc. Charged depth filtration of antigen-binding proteins
GB201711481D0 (en) 2017-07-17 2017-08-30 Ucb Biopharma Sprl Protein purification
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
US10792618B2 (en) 2018-06-19 2020-10-06 Sartorius Stedim Biotech Gmbh Particle separation and/or purification of a fluid
GB201815405D0 (en) * 2018-09-21 2018-11-07 Fujifilm Mfg Europe Bv Membranes suitable for detecting, filtering and/or purifying biomolecules
WO2020128797A1 (en) * 2018-12-21 2020-06-25 3M Innovative Properties Company Method for testing a chromatography device used for ion exchange
AR119264A1 (es) * 2019-06-05 2021-12-09 Genentech Inc Método para reutilización de cromatografía
US11416468B2 (en) * 2020-07-21 2022-08-16 International Business Machines Corporation Active-active system index management
CN116371011B (zh) * 2023-05-26 2023-08-18 湖南杰萃生物技术有限公司 一种从桑叶中提取黄酮和生物碱的方法
CN117866038B (zh) * 2024-03-11 2024-05-28 北京百力格生物科技有限公司 纯化含有宿主核酸的带亲和标签的酸性蛋白的方法

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE266710C (es)
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
JPS6150925A (ja) * 1984-08-17 1986-03-13 Toray Ind Inc 抗原または抗体の精製方法
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US5091178A (en) 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
JPH0788395B2 (ja) * 1987-10-23 1995-09-27 シェリング・コーポレーション タンパク質の精製方法
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
ATE113846T1 (de) 1988-06-21 1994-11-15 Genentech Inc Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
ATE135397T1 (de) 1988-09-23 1996-03-15 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
JP2844346B2 (ja) * 1989-05-31 1999-01-06 昭 梶 新規ペプチドならびに新規dna
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
DE122006000006I2 (de) 1991-08-14 2011-06-16 Genentech Inc Veränderte Immunglobuline für spezifische FC-Epsilon Rezeptoren
ES2241710T3 (es) 1991-11-25 2005-11-01 Enzon, Inc. Procedimiento para producir proteinas multivalentes de union a antigeno.
CA2372813A1 (en) 1992-02-06 1993-08-19 L.L. Houston Biosynthetic binding protein for cancer marker
AU687755B2 (en) 1992-08-21 1998-03-05 Genentech Inc. Method for treating an LFA-1-mediated disorder
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5595721A (en) 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
HU218159B (hu) * 1993-09-21 2000-06-28 Hemosol Inc. Kiszorításos kromatográfiás eljárás tisztított hemoglobintermék előállítására
EP0733207B1 (en) 1993-12-10 1997-08-27 Genentech, Inc. Methods for diagnosis of allergy and screening of anti-allergy therapeutics
JP3825798B2 (ja) 1994-01-18 2006-09-27 ジェネンテク,インコーポレイテッド IgEアンタゴニストを用いる寄生虫感染症の治療法
EP0749488A1 (en) 1994-03-03 1996-12-27 Genentech, Inc. Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
JPH11507535A (ja) 1995-06-07 1999-07-06 イムクローン システムズ インコーポレイテッド 腫瘍の成長を抑制する抗体および抗体フラグメント類
DK0877626T3 (da) 1996-01-23 2002-12-30 Univ Vermont Anti-CD18 antistoffer til anvendelse mod slagtilfælde
CA2242931A1 (en) * 1996-01-31 1997-08-07 David Francis Elgar Production of an immunoglobulin enriched fraction from whey protein solutions
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
KR100532178B1 (ko) 1996-11-27 2005-12-01 제넨테크, 인크. 인간화 항-CD11a 항체
NZ500078A (en) 1997-04-07 2001-10-26 Genentech Inc Humanized anti-VEGF antibodies and their use in inhibiting VEGF-induced angiogenesis in mammals
DK1860187T3 (da) 1997-05-15 2011-10-31 Genentech Inc Apo-2-receptor
US6054293A (en) 1997-07-08 2000-04-25 The Regents Of The University Of California Semaphorin receptors
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
IL146954A0 (en) 1999-06-25 2002-08-14 Genentech Inc HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES
IL149116A0 (en) 1999-10-29 2002-11-10 Genentech Inc Anti-prostate stem cell antigen (psca) antibody compositions and methods of use
US20020012982A1 (en) 2000-07-13 2002-01-31 Invitrogen Corporation Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix
UA83458C2 (uk) 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
US7321026B2 (en) 2001-06-27 2008-01-22 Skytech Technology Limited Framework-patched immunoglobulins
AU2002325755A1 (en) 2001-09-18 2003-04-01 Affinium Pharmaceuticals, Inc. Methods and apparatuses for purification
WO2003033656A2 (en) 2001-10-16 2003-04-24 Exelixis, Inc. MSREBPs AS MODIFIERS OF THE SREBP PATHWAY AND METHODS OF USE
WO2003033658A2 (en) 2001-10-17 2003-04-24 Human Genome Sciences, Inc. Neutrokine-alpha and neutrokine-alpha splice variant
US20040093621A1 (en) 2001-12-25 2004-05-13 Kyowa Hakko Kogyo Co., Ltd Antibody composition which specifically binds to CD20
AU2003208415B2 (en) 2002-02-14 2009-05-28 Immunomedics, Inc. Anti-CD20 antibodies and fusion proteins thereof and methods of use
PL218660B1 (pl) 2002-10-17 2015-01-30 Genmab As Izolowane ludzkie przeciwciało monoklonalne wiążące ludzki CD20, związane z tym przeciwciałem transfektoma, komórka gospodarza, transgeniczne zwierzę lub roślina, kompozycja, immunokoniugat, cząsteczka bispecyficzna, wektor ekspresyjny, kompozycja farmaceutyczna, zastosowanie medyczne, zestaw oraz przeciwciało antyidiotypowe i jego zastosowanie
EP2301966A1 (en) 2002-12-16 2011-03-30 Genentech, Inc. Immunoglobulin variants and uses thereof
CN1206240C (zh) * 2003-04-07 2005-06-15 中国科学院生态环境研究中心 高效离子交换膜色谱纯化卵黄蛋白原技术
KR101412271B1 (ko) 2003-05-09 2014-06-25 듀크 유니버시티 Cd20-특이적 항체 및 이를 이용한 방법
AR044388A1 (es) 2003-05-20 2005-09-07 Applied Molecular Evolution Moleculas de union a cd20
AU2004263538B2 (en) 2003-08-08 2009-09-17 Immunomedics, Inc. Bispecific antibodies for inducing apoptosis of tumor and diseased cells
US8147832B2 (en) 2003-08-14 2012-04-03 Merck Patent Gmbh CD20-binding polypeptide compositions and methods
US20080274501A1 (en) * 2007-05-02 2008-11-06 Chenming Zhang Method of purifying acidic proteins expressed in plants
US9433922B2 (en) 2007-08-14 2016-09-06 Emd Millipore Corporation Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
EP2226331A4 (en) * 2007-10-26 2012-02-08 Asahi Kasei Chemicals Corp METHOD OF PURIFYING PROTEINS
SI2215117T2 (en) 2007-10-30 2018-04-30 Genentech, Inc. Purification of the antibody by cation exchange chromatography
WO2009135656A1 (en) * 2008-05-06 2009-11-12 Lonza Biologics Plc. A method for the purification of antibodies using displacement chromatography
DK2848625T3 (da) 2008-08-14 2019-10-07 Genentech Inc Fremgangsmåder til fjernelse af en kontaminant under anvendelse af ion bytningsmembrankromatografi med forskydning af naturligt forekommende proteiner
GB0816242D0 (en) 2008-09-05 2008-10-15 Immunobiology Ltd Method of purifying protien complexes
NZ597809A (en) 2009-08-06 2014-05-30 Genentech Inc Method to improve virus removal in protein purification
WO2011028753A1 (en) * 2009-09-01 2011-03-10 Genentech, Inc. Enhanced protein purification through a modified protein a elution
ES2617777T5 (es) * 2010-04-23 2022-10-13 Hoffmann La Roche Producción de proteínas heteromultiméricas
PL2575847T5 (pl) 2010-05-25 2022-07-18 F.Hoffmann-La Roche Ag Sposoby oczyszczania polipeptydów
KR20140084124A (ko) * 2011-10-03 2014-07-04 사켐,인코포레이티드 소수성 치환 크로마토그래피용 음이온 디스플레이서 분자
JP6605202B2 (ja) 2011-12-22 2019-11-13 ジェネンテック, インコーポレイテッド イオン交換膜クロマトグラフィー
JP5731726B1 (ja) 2014-06-26 2015-06-10 楽天株式会社 情報処理装置、情報処理方法及び情報処理プログラム

Also Published As

Publication number Publication date
MX2014007622A (es) 2014-09-22
JP7402011B2 (ja) 2023-12-20
US11945837B2 (en) 2024-04-02
JP2015503524A (ja) 2015-02-02
KR102067075B1 (ko) 2020-01-17
AU2018200194B2 (en) 2019-11-14
AU2012355356B2 (en) 2017-10-12
JP7359807B2 (ja) 2023-10-11
HRP20181846T1 (hr) 2018-12-28
JP2022101557A (ja) 2022-07-06
US20200102346A1 (en) 2020-04-02
WO2013096322A8 (en) 2014-02-27
KR20200008022A (ko) 2020-01-22
HK1203526A1 (en) 2015-10-30
EP3492486A1 (en) 2019-06-05
IL267585B (en) 2022-09-01
EP2794635A1 (en) 2014-10-29
PL2794635T3 (pl) 2019-02-28
KR20210025692A (ko) 2021-03-09
WO2013096322A1 (en) 2013-06-27
CN104125963B (zh) 2018-08-17
NZ626949A (en) 2016-11-25
MX2018013356A (es) 2020-09-14
JP2018109024A (ja) 2018-07-12
ZA201404593B (en) 2022-12-21
SG11201403437TA (en) 2014-07-30
EP2794635B1 (en) 2018-09-12
ZA201903994B (en) 2023-12-20
RU2014130017A (ru) 2016-02-10
CA2859376A1 (en) 2013-06-27
IL267585A (en) 2019-08-29
AU2012355356A1 (en) 2014-07-10
IL233158A0 (en) 2014-07-31
TR201815709T4 (tr) 2018-11-21
ES2697676T3 (es) 2019-01-25
CA2859376C (en) 2022-04-19
BR112014015101A2 (pt) 2017-06-13
CN104125963A (zh) 2014-10-29
EP2794635B8 (en) 2018-11-14
JP2021169454A (ja) 2021-10-28
BR112014015101A8 (pt) 2021-06-08
JP2020040952A (ja) 2020-03-19
JP6605202B2 (ja) 2019-11-13
AR089362A1 (es) 2014-08-20
KR20140114834A (ko) 2014-09-29
US20140348845A1 (en) 2014-11-27
AU2020201070A1 (en) 2020-03-05
RU2648999C2 (ru) 2018-03-29
WO2013096322A9 (en) 2013-08-22
US10364268B2 (en) 2019-07-30
IL233158B (en) 2019-07-31
AU2018200194A1 (en) 2018-02-01
MY172426A (en) 2019-11-25
CN108892706A (zh) 2018-11-27
SI2794635T1 (sl) 2018-12-31
US20240247027A1 (en) 2024-07-25

Similar Documents

Publication Publication Date Title
ZA201903994B (en) Ion exchange membrane chromatography
CY1122221T1 (el) Μεθοδοι αφαιρεσης ρυπου χρησιμοποιωντας ιοντοανταλλακτικη μεμβρανικη χρωματογραφια μετατοπισης γηγενων πρωτεϊνων
MX344268B (es) Proceso para purificacion de proteinas.
PH12013501128A1 (en) Antibody purification by cation exchange chromatography
WO2013177118A3 (en) Novel purification of non-human antibodies using protein a affinity chromatography
EA201592192A1 (ru) Способ очистки моноклональных антител
MX2012000841A (es) Optimizacion de la produccion de anticuerpos.
WO2011106750A3 (en) Method and apparatus for enhanced lifetime and performance of ion source in an ion implantation system
EP2522724A4 (en) POLYPEPTIDE MODIFYING METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS
MX2013003182A (es) Purificacion de anticuerpos por cromatografia de lecho movil simulada.
NZ603616A (en) Apparatus and process of purification of proteins
UA100901C2 (ru) Способ очищения фактора свертывания крови viii
EA201070987A1 (ru) Очищенные гибридные белки иммуноглобулина и способы их очищения
RU2011137030A (ru) Способы очистки малых модулярных иммунофармацевтических белков
MX342235B (es) Metodo optimizado para captura de anticuerpo por cromatografia de modo mixto.
RU2014111820A (ru) Способы элиминации вируса
MX2017011121A (es) Uso de lavados alcalinos durante la cromatografia para remover impurezas.
MX368161B (es) Metodo para purificar el virus de rabia.
EA201300524A1 (ru) Очистка антител ионообменной хроматографией в едином блоке
AU2014370873A1 (en) Method for purifying antibody having low isoelectric point
EA201291224A1 (ru) Способ извлечения бетаина из мелассы
WO2012108669A3 (ko) 우라닐 이온-특이적 dna 앱타머
WO2011130809A3 (en) Fractionation of ions from aqueous solutions by electrodialysis using monovalent selective membranes
MY160083A (en) A method for isolating shikimic acid from oil palm waste
MX2013013224A (es) Procedimiento de purificacion de proteinas de bajo ph.

Legal Events

Date Code Title Description
FG Grant or registration